Shanghai Universal Biotech Co.,Ltd.

SZSE:301166 Rapport sur les actions

Capitalisation boursière : CN¥2.6b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Shanghai Universal BiotechLtd Bilan de santé

Santé financière contrôle des critères 6/6

Shanghai Universal BiotechLtd has a total shareholder equity of CN¥2.1B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.4B and CN¥242.3M respectively.

Informations clés

0%

Ratio d'endettement

CN¥0

Dette

Ratio de couverture des intérêtsn/a
Argent liquideCN¥1.41b
Fonds propresCN¥2.12b
Total du passifCN¥242.28m
Total des actifsCN¥2.36b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

What Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) 25% Share Price Gain Is Not Telling You

May 08
What Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) 25% Share Price Gain Is Not Telling You

Shanghai Universal BiotechLtd's (SZSE:301166) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 03
Shanghai Universal BiotechLtd's (SZSE:301166) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Analyse de la situation financière

Passif à court terme: 301166's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥210.4M).

Passif à long terme: 301166's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥31.9M).


Historique et analyse du ratio d'endettement

Niveau d'endettement: 301166 is debt free.

Réduire la dette: 301166 has no debt compared to 5 years ago when its debt to equity ratio was 9.7%.

Couverture de la dette: 301166 has no debt, therefore it does not need to be covered by operating cash flow.

Couverture des intérêts: 301166 has no debt, therefore coverage of interest payments is not a concern.


Bilan


Découvrir des entreprises saines